FDA – Penn Program on Regulation

Tag: FDA

FDA Seems Poised to Approve a New Drug for ALS, but Does it Work?

September 21, 2022• PPR Affiliates in the News

Read More →

The Debate over a New ALS Drug Harkens Back to the Aduhelm Controversy

September 8, 2022• PPR Affiliates in the News

Holly Fernandez Lynch in Washington Post, Sep 8, 2022...

Read More →

FDA Still Skeptical of ALS Drug Ahead of High-Stakes Meeting

September 2, 2022• PPR Affiliates in the News

Holly Fernandez Lynch in WRAL, Sep 2, 2022...

Read More →